Report Detail
Global Diabetes Therapeutics and Diagnostics Market Professional Survey Report 2019
- RnM3720944 |
- 03 September, 2019 |
- Global |
- 125 Pages |
- QYResearch |
- Pharma & Healthcare
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
The global Diabetes Therapeutics and Diagnostics market was valued at 128000 million US$ in 2018 and will reach 180600 million US$ by the end of 2025, growing at a CAGR of 4.4% during 2019-2025.
This report focuses on Diabetes Therapeutics and Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Diabetes Therapeutics and Diagnostics market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Diabetes Therapeutics and Diagnostics in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Diabetes Therapeutics and Diagnostics manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
77 Elektronika Kft.
A. Menarini Diagnostics S.R.L
Abbott Laboratories
Agamatrix Inc.
Animas Corp.
Ascensia
Becton Dickinson
Debiotech S.A.
Eli Lilly And Co.
Glaxo Smithkline
Inlight Solutions Inc.
Johnson & Johnson
Lifescan Inc.
Medtronic
Merck & Co.
Merck KGAA
Nipro Corp.
Novartis Pharma Ag
Novo Nordisk A/S
Owen Mumford Ltd.
Palco Labs Inc.
Roche
Sanofi
Takeda Pharmaceutical Co. Ltd.
Terumo Corp.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Insulin
Insulin Delivery
Oral Hypoglycemic Drugs
Diagnosis And Monitoring
Others
Segment by Application
Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes
Others
Table of Contents
Executive Summary
1 Industry Overview of Diabetes Therapeutics and Diagnostics
- 1.1 Definition of Diabetes Therapeutics and Diagnostics
- 1.2 Diabetes Therapeutics and Diagnostics Segment by Type
- 1.2.1 Global Diabetes Therapeutics and Diagnostics Production Growth Rate Comparison by Types (2014-2025)
- 1.2.2 Insulin
- 1.2.3 Insulin Delivery
- 1.2.4 Oral Hypoglycemic Drugs
- 1.2.5 Diagnosis And Monitoring
- 1.2.6 Others
- 1.3 Diabetes Therapeutics and Diagnostics Segment by Applications
- 1.3.1 Global Diabetes Therapeutics and Diagnostics Consumption Comparison by Applications (2014-2025)
- 1.3.2 Type 1 Diabetes
- 1.3.3 Type 2 Diabetes
- 1.3.4 Gestational Diabetes
- 1.3.5 Others
- 1.4 Global Diabetes Therapeutics and Diagnostics Overall Market
- 1.4.1 Global Diabetes Therapeutics and Diagnostics Revenue (2014-2025)
- 1.4.2 Global Diabetes Therapeutics and Diagnostics Production (2014-2025)
- 1.4.3 North America Diabetes Therapeutics and Diagnostics Status and Prospect (2014-2025)
- 1.4.4 Europe Diabetes Therapeutics and Diagnostics Status and Prospect (2014-2025)
- 1.4.5 China Diabetes Therapeutics and Diagnostics Status and Prospect (2014-2025)
- 1.4.6 Japan Diabetes Therapeutics and Diagnostics Status and Prospect (2014-2025)
- 1.4.7 Southeast Asia Diabetes Therapeutics and Diagnostics Status and Prospect (2014-2025)
- 1.4.8 India Diabetes Therapeutics and Diagnostics Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
- 2.1 Raw Material and Suppliers
- 2.2 Manufacturing Cost Structure Analysis of Diabetes Therapeutics and Diagnostics
- 2.3 Manufacturing Process Analysis of Diabetes Therapeutics and Diagnostics
- 2.4 Industry Chain Structure of Diabetes Therapeutics and Diagnostics
3 Development and Manufacturing Plants Analysis of Diabetes Therapeutics and Diagnostics
- 3.1 Capacity and Commercial Production Date
- 3.2 Global Diabetes Therapeutics and Diagnostics Manufacturing Plants Distribution
- 3.3 Major Manufacturers Technology Source and Market Position of Diabetes Therapeutics and Diagnostics
- 3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
- 4.1 Diabetes Therapeutics and Diagnostics Production and Capacity Analysis
- 4.2 Diabetes Therapeutics and Diagnostics Revenue Analysis
- 4.3 Diabetes Therapeutics and Diagnostics Price Analysis
- 4.4 Market Concentration Degree
5 Diabetes Therapeutics and Diagnostics Regional Market Analysis
- 5.1 Diabetes Therapeutics and Diagnostics Production by Regions
- 5.1.1 Global Diabetes Therapeutics and Diagnostics Production by Regions
- 5.1.2 Global Diabetes Therapeutics and Diagnostics Revenue by Regions
- 5.2 Diabetes Therapeutics and Diagnostics Consumption by Regions
- 5.3 North America Diabetes Therapeutics and Diagnostics Market Analysis
- 5.3.1 North America Diabetes Therapeutics and Diagnostics Production
- 5.3.2 North America Diabetes Therapeutics and Diagnostics Revenue
- 5.3.3 Key Manufacturers in North America
- 5.3.4 North America Diabetes Therapeutics and Diagnostics Import and Export
- 5.4 Europe Diabetes Therapeutics and Diagnostics Market Analysis
- 5.4.1 Europe Diabetes Therapeutics and Diagnostics Production
- 5.4.2 Europe Diabetes Therapeutics and Diagnostics Revenue
- 5.4.3 Key Manufacturers in Europe
- 5.4.4 Europe Diabetes Therapeutics and Diagnostics Import and Export
- 5.5 China Diabetes Therapeutics and Diagnostics Market Analysis
- 5.5.1 China Diabetes Therapeutics and Diagnostics Production
- 5.5.2 China Diabetes Therapeutics and Diagnostics Revenue
- 5.5.3 Key Manufacturers in China
- 5.5.4 China Diabetes Therapeutics and Diagnostics Import and Export
- 5.6 Japan Diabetes Therapeutics and Diagnostics Market Analysis
- 5.6.1 Japan Diabetes Therapeutics and Diagnostics Production
- 5.6.2 Japan Diabetes Therapeutics and Diagnostics Revenue
- 5.6.3 Key Manufacturers in Japan
- 5.6.4 Japan Diabetes Therapeutics and Diagnostics Import and Export
- 5.7 Southeast Asia Diabetes Therapeutics and Diagnostics Market Analysis
- 5.7.1 Southeast Asia Diabetes Therapeutics and Diagnostics Production
- 5.7.2 Southeast Asia Diabetes Therapeutics and Diagnostics Revenue
- 5.7.3 Key Manufacturers in Southeast Asia
- 5.7.4 Southeast Asia Diabetes Therapeutics and Diagnostics Import and Export
- 5.8 India Diabetes Therapeutics and Diagnostics Market Analysis
- 5.8.1 India Diabetes Therapeutics and Diagnostics Production
- 5.8.2 India Diabetes Therapeutics and Diagnostics Revenue
- 5.8.3 Key Manufacturers in India
- 5.8.4 India Diabetes Therapeutics and Diagnostics Import and Export
6 Diabetes Therapeutics and Diagnostics Segment Market Analysis (by Type)
- 6.1 Global Diabetes Therapeutics and Diagnostics Production by Type
- 6.2 Global Diabetes Therapeutics and Diagnostics Revenue by Type
- 6.3 Diabetes Therapeutics and Diagnostics Price by Type
7 Diabetes Therapeutics and Diagnostics Segment Market Analysis (by Application)
- 7.1 Global Diabetes Therapeutics and Diagnostics Consumption by Application
- 7.2 Global Diabetes Therapeutics and Diagnostics Consumption Market Share by Application (2014-2019)
8 Diabetes Therapeutics and Diagnostics Major Manufacturers Analysis
- 8.1 77 Elektronika Kft.
- 8.1.1 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Production Sites and Area Served
- 8.1.2 77 Elektronika Kft. Product Introduction, Application and Specification
- 8.1.3 77 Elektronika Kft. Diabetes Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.1.4 Main Business and Markets Served
- 8.2 A. Menarini Diagnostics S.R.L
- 8.2.1 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Production Sites and Area Served
- 8.2.2 A. Menarini Diagnostics S.R.L Product Introduction, Application and Specification
- 8.2.3 A. Menarini Diagnostics S.R.L Diabetes Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.2.4 Main Business and Markets Served
- 8.3 Abbott Laboratories
- 8.3.1 Abbott Laboratories Diabetes Therapeutics and Diagnostics Production Sites and Area Served
- 8.3.2 Abbott Laboratories Product Introduction, Application and Specification
- 8.3.3 Abbott Laboratories Diabetes Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.3.4 Main Business and Markets Served
- 8.4 Agamatrix Inc.
- 8.4.1 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Production Sites and Area Served
- 8.4.2 Agamatrix Inc. Product Introduction, Application and Specification
- 8.4.3 Agamatrix Inc. Diabetes Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.4.4 Main Business and Markets Served
- 8.5 Animas Corp.
- 8.5.1 Animas Corp. Diabetes Therapeutics and Diagnostics Production Sites and Area Served
- 8.5.2 Animas Corp. Product Introduction, Application and Specification
- 8.5.3 Animas Corp. Diabetes Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.5.4 Main Business and Markets Served
- 8.6 Ascensia
- 8.6.1 Ascensia Diabetes Therapeutics and Diagnostics Production Sites and Area Served
- 8.6.2 Ascensia Product Introduction, Application and Specification
- 8.6.3 Ascensia Diabetes Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.6.4 Main Business and Markets Served
- 8.7 Becton Dickinson
- 8.7.1 Becton Dickinson Diabetes Therapeutics and Diagnostics Production Sites and Area Served
- 8.7.2 Becton Dickinson Product Introduction, Application and Specification
- 8.7.3 Becton Dickinson Diabetes Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.7.4 Main Business and Markets Served
- 8.8 Debiotech S.A.
- 8.8.1 Debiotech S.A. Diabetes Therapeutics and Diagnostics Production Sites and Area Served
- 8.8.2 Debiotech S.A. Product Introduction, Application and Specification
- 8.8.3 Debiotech S.A. Diabetes Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.8.4 Main Business and Markets Served
- 8.9 Eli Lilly And Co.
- 8.9.1 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Production Sites and Area Served
- 8.9.2 Eli Lilly And Co. Product Introduction, Application and Specification
- 8.9.3 Eli Lilly And Co. Diabetes Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.9.4 Main Business and Markets Served
- 8.10 Glaxo Smithkline
- 8.10.1 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Production Sites and Area Served
- 8.10.2 Glaxo Smithkline Product Introduction, Application and Specification
- 8.10.3 Glaxo Smithkline Diabetes Therapeutics and Diagnostics Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
- 8.10.4 Main Business and Markets Served
- 8.11 Inlight Solutions Inc.
- 8.12 Johnson & Johnson
- 8.13 Lifescan Inc.
- 8.14 Medtronic
- 8.15 Merck & Co.
- 8.16 Merck KGAA
- 8.17 Nipro Corp.
- 8.18 Novartis Pharma Ag
- 8.19 Novo Nordisk A/S
- 8.20 Owen Mumford Ltd.
- 8.21 Palco Labs Inc.
- 8.22 Roche
- 8.23 Sanofi
- 8.24 Takeda Pharmaceutical Co. Ltd.
- 8.25 Terumo Corp.
9 Development Trend of Analysis of Diabetes Therapeutics and Diagnostics Market
- 9.1 Global Diabetes Therapeutics and Diagnostics Market Trend Analysis
- 9.1.1 Global Diabetes Therapeutics and Diagnostics Market Size (Volume and Value) Forecast 2019-2025
- 9.2 Diabetes Therapeutics and Diagnostics Regional Market Trend
- 9.2.1 North America Diabetes Therapeutics and Diagnostics Forecast 2019-2025
- 9.2.2 Europe Diabetes Therapeutics and Diagnostics Forecast 2019-2025
- 9.2.3 China Diabetes Therapeutics and Diagnostics Forecast 2019-2025
- 9.2.4 Japan Diabetes Therapeutics and Diagnostics Forecast 2019-2025
- 9.2.5 Southeast Asia Diabetes Therapeutics and Diagnostics Forecast 2019-2025
- 9.2.6 India Diabetes Therapeutics and Diagnostics Forecast 2019-2025
- 9.3 Diabetes Therapeutics and Diagnostics Market Trend (Product Type)
- 9.4 Diabetes Therapeutics and Diagnostics Market Trend (Application)
- 10.1 Marketing Channel
- 10.1.1 Direct Marketing
- 10.1.2 Indirect Marketing
- 10.3 Diabetes Therapeutics and Diagnostics Customers
11 Market Dynamics
- 11.1 Market Trends
- 11.2 Opportunities
- 11.3 Market Drivers
- 11.4 Challenges
- 11.5 Influence Factors
12 Conclusion
13 Appendix
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Diabetes Therapeutics and Diagnostics. Industry analysis & Market Report on Diabetes Therapeutics and Diagnostics is a syndicated market report, published as Global Diabetes Therapeutics and Diagnostics Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Diabetes Therapeutics and Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
